Osteal Therapeutics

BiotechnologySeries DDallas, USostealtx.com

Latest round

Series D

Last raised

Jun 2024

Total raised

$110M

Investors

7

About Osteal Therapeutics

Founded in 2013 and based in Texas, US, Osteal Therapeutics, Inc. operates as a developer of biopharmaceutical drugs that focuses on developing medicines for the treatment of musculoskeletal infections. Jude Paganelli (CTO) and Brian de Beaubin (CMO) are the co-founders of the company. In June 2024, Osteal Therapeutics, Inc., including Johnson & Johnson Innovation, Gideon Strategic Partners, and HM Capital.79 million post-money. The company’s primary product, VT-X7, improves outcomes for patients with musculoskeletal infections, including periprosthetic joint infections of the hip and knee. The firm is developing targeted therapies to reduce mortality, morbidity, and healthcare costs associated with these infections. In addition, Osteal is working on the APEX-2 clinical trial, which compares the procedure's performance with two-stage surgery.

Who invested in Osteal Therapeutics

7 investors across 4 rounds

See all investors in Osteal Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Jun 5, 2024

    Amount

    $50M

    Investors

    Locked

  2. Series C

    Aug 29, 2023

    Amount

    $22M

    Investors

    Locked

  3. Series B

    Dec 29, 2021

    Amount

    $30M

    Investors

    Locked

  4. Series A

    Apr 6, 2018

    Amount

    $7.8M

    Investors

    Locked

Questions about Osteal Therapeutics

Who invested in Osteal Therapeutics?

Osteal Therapeutics has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Osteal Therapeutics raised?

Osteal Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did Osteal Therapeutics last raise money?

Osteal Therapeutics's most recent round on record is a Series D, in Jun 2024.

What does Osteal Therapeutics do?

Founded in 2013 and based in Texas, US, Osteal Therapeutics, Inc.

Where is Osteal Therapeutics headquartered?

Osteal Therapeutics is headquartered in Dallas, US.

Which VCs invest in companies like Osteal Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Osteal Therapeutics's stage. Their profiles are linked below.

Raising like Osteal Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.